Organoids and metastatic orthotopic mouse model for mismatch repair-deficient colorectal cancer
ConclusionsThe established organoids with characteristics of MSI-H cancers can be used to study MMRd cancer biology. The orthotopic model, with its distant metastasis and expressing frameshift peptides, is suitable for evaluating the efficacy of neoantigen-based vaccines or anticancer drugs in combination with other therapies.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research
More News: Adenocarcinoma | Biology | Cancer | Cancer & Oncology | Cancer Vaccines | Colorectal Cancer | Epithelial Cancer | Gastroschisis Repair | Genetics | HNPCC | Immunotherapy | Liver | Lynch Syndrome | Stem Cell Therapy | Stem Cells | Study | Urology & Nephrology | Vaccines